| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Mar―10 |
Role of Supplements in the Management of COVID-19 - A Comprehensive Review |
Rajkapoor Balasubramanian, Naina Mohamed Pakkir Maideen, Sudha Muthusamy, Sambathkumar Ramanathan, Mohamed Harsath Jahir Hussain |
| 2 |
[GO] |
2023―Mar―06 |
Biochemical, serological and immunological tests for diagnosis of coronavirus disease 2019 (COVID-19) patients: a comprehensive systematic review and meta-analysis |
Reza Ranjbar, Milad Azami, Amirreza Jamshidbeigi, Hadi Esmaeili Gouvarchin Ghaleh |
| 3 |
[GO] |
2023―Mar―02 |
Can the new BA.2.75 sub-variant lead to one more COVID-19 wave? |
Sukhes Mukherjee, Suman Kumar Ray |
| 4 |
[GO] |
2023―Feb―28 |
Marburg Virus- A threat during SARS-CoV-2 era: A Review |
Sumel Ashique, Vatan Chaudhary, Soumen Pal, Jonee Panwar, Mukesh Kumar, Soumi Pramanik, et al. (+2) Abhipsa Sinha, Anagh Mukherjee |
| 5 |
[GO] |
2023―Feb―24 |
Anti-Covid-19 Vaccination, Covid-19, and Female Contraception: The Exacerbated Risks (Thromboembolism) of the Estrogen-progestin Pill |
Jean-Marc Sabatier, Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, Christian Legros |
| 6 |
[GO] |
2023―Feb―24 |
Potential of Black Seeds (Nigella Sativa) in the Management of Long
COVID or Post-acute Sequelae of COVID-19 (PASC) and Persistent
COVID-19 Symptoms - An Insight |
Naina Mohamed Pakkir Maideen, Abdurazak Hassan Jumale, Ibrahim Ramadan Barakat, Ayesha Khalifa Albasti |
| 7 |
[GO] |
2023―Feb―10 |
SIBO: the trail of a "new" human pathology associated with multiple severe and disabling Covid-19 and long Covid symptoms or induced by the anti-Covid-19 vaccine |
Jean-Marc Sabatier, Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, Christian Legros |
| 8 |
[GO] |
2023―Jan―25 |
Estimating methods of the undetected infections in the COVID-19 outbreak: a systematic review |
SeyedAhmad SeyedAlinaghi, Esmaeil Mehraeen, Zahra Pashaei, Fatemeh Khajeh Akhtaran, Mohsen Dashti, Arian Afzalian, et al. (+8) Afsaneh Ghasemzadeh, Pooria Asili, Mohammad Saeed Kahrizi, Maryam Mirahmad, Ensiyeh Rahimi, Parisa Matini, Amir Masoud Afsahi, Omid Dadras |
| 9 |
[GO] |
2023―Jan―23 |
The impact of COVID-19 pandemic on the levels of physical activity: A systematic review |
SeyedAhmad SeyedAlinaghi, Esmaeil Mehraeen, Amirali Karimi, Seyed Peyman Mirghaderi, Pegah Mirzapour, Zahra Pashaei, et al. (+14) Kowsar Qaderi, Amir Masoud Afsahi, Alireza Barzegary, Parsa Mohammadi, Alireza Shojaei, Solmaz Saeidi, Fatemeh Afroughi, Mehrzad MohsseniPour, Nazanin Janfaza, Omid Dadras, Ava Amiri, Kimia Azad, Marcarious M. Tantuoyir, Fabricio Voltarelli |
| 10 |
[GO] |
2023―Jan―12 |
Why can high-level athletes develop very severe or fatal forms after intense exercise following SARS-CoV-2 infection or anti-Covid vaccination? |
Jean-Marc Sabatier, Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, Christian Legros |
| 11 |
[GO] |
2023―Jan―05 |
COVID-19 and Ehlers-Danlos syndrome: the dangers of the Spike protein of SARS-CoV-2 |
Jean-Marc Sabatier, Ziad Fajloun, Christian Legros |
| 12 |
[GO] |
2022―Nov―02 |
Discharge of Confirmed COVID-19 Patients Based on WHO or Regional
Criteria? A Cohort Study |
Jamshid Vafaeimanesh, Seyed Hasan Adeli, Mahmoud Parham, Akram Asghari, Mohammad Bagherzade, Rasoul Shajari, et al. (+13) Reihane Tabarraii, Masoumeh Shakeri, Amir Jabbari, Saeede Jafari, Sajjad Ahmadpour, Mohamad Amin Habibi, Javad Khodadai, Hamed Shafiee, Narges Eskandari, Davoud Olad Dameshghi, Maryam Masoumi, Seyed Yaser Foroghi Ghomi, Ali Ebrazeh |
| 13 |
[GO] |
2022―Oct―28 |
Interplay between SARS-CoV-2 and Cancer: Plausible Risk factors, Cellular Immune Responses, Cancer Directed Therapy- Current Challenges |
Sukhes Mukherjee, Suman Kumar Ray |
| 14 |
[GO] |
2022―Sep―03 |
COVID-19 Mass Vaccination and Flu season: Concern for Decreased Public Health Measures and worsening the influenza situation |
Shahab Falahi, Azra Kenarkoohi, Jasem Mohamadi, Iraj Pakzad, Hojjat Sayyadi |
| 15 |
[GO] |
2022―Sep―03 |
Molecular docking study of potential antimicrobial photodynamic therapy as a potent inhibitor of SARS-CoV-2 main protease: An in silico insight |
Abbas Bahador, Maryam Pourhajibagher |
| 16 |
[GO] |
2022―Aug―31 |
A New Year, Newfangled COVID-19 Variant B.1.640.2 (IHU): What We Know So Far? |
Sukhes Mukherjee, Suman Kumar Ray |
| 17 |
[GO] |
2022―Aug―19 |
Latest in COVID-19 Vaccine 'Candidates' Race |
Manar Fayiz Atoum, Dalia Abu Zreig, Laith M Abu Zreig |
| 18 |
[GO] |
2022―Jul―31 |
A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19) |
Suraj N. Mali |
| 19 |
[GO] |
2022―Jul―31 |
Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report. |
SeyedAhmad SeyedAlinaghi |
| 20 |
[GO] |
2022―Jul―31 |
Efficacy of Lopinavir/Ritonavir Compared With Standard Care for Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review. |
Timotius Ivan Hariyanto |
| 21 |
[GO] |
2022―Jul―31 |
A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case |
Fereshteh Ghiasvand |
| 22 |
[GO] |
2022―Jul―31 |
Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients |
Cédric Annweiler |
| 23 |
[GO] |
2022―Jul―31 |
Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report |
Zahra Ahmadinejad |
| 24 |
[GO] |
2022―Jul―31 |
Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction. |
Nahid Akhtar |
| 25 |
[GO] |
2022―Jul―31 |
Transmission Modes of COVID-19: A Systematic Review. |
Esmaeil Mehraeen |
| 26 |
[GO] |
2022―Jul―31 |
Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital |
Fereshteh Ghiasvand |
| 27 |
[GO] |
2022―Jul―31 |
SARS-CoV-2 & Covid-19: Key-Roles of the ‘Renin-Angiotensin’ System / Vitamin D Impacting Drug and Vaccine Developments |
Zhijian Cao |
| 28 |
[GO] |
2022―Jul―31 |
Chloroquine as Chemoprophylaxis for COVID-19: Will This Work. |
Sherief Abd-Elsalam |
| 29 |
[GO] |
2022―Jul―31 |
In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases. |
Trinath Chowdhury |
| 30 |
[GO] |
2022―Jul―31 |
SARS-CoV-2: The Path of Prevention and Control |
Amal A. Mohamed |
| 31 |
[GO] |
2022―Jun―21 |
MMP3 in Severe COVID-19: A Biomarker or Therapeutic Target? |
Sultan Almuntashiri, Duo Zhang, Payaningal R. Somanath, Andrea Sikora |
| 32 |
[GO] |
2022―Jun―13 |
Postural orthostatic tachycardia syndrome and orthostatic hypotension post COVID-19 |
Masoud Eslami, Reza Mollazadeh, Shayan Mirshafiee, Parisa Sehat, Fatemeh Alizadeh, Zahra Emkanjoo, et al. (+2) Vahideh Laleh far, Elnaz Shahmohamadi |
| 33 |
[GO] |
2022―Jun―07 |
Divulging Incipient SARS-CoV-2 Delta (B.1.617.2) Variant: Possible Interference with Global Scenario |
Suman Kumar Ray, Sukhes Mukherjee |
| 34 |
[GO] |
2022―May―31 |
COVID-19 Associated Acute Pancreatitis: A Case Series from India |
Jitendra Singh, Nilesh Kumar, Kailash Kumar, Anju Dinkar |
| 35 |
[GO] |
2022―May―27 |
Epidemiological study of COVID-19 in Iran and the world: a review study |
Nasges Ansari, Samira Shokri, Mohadeseh Pirhadi, Saber Abbaszadeh, Aliasghar Manouchehri |
| 36 |
[GO] |
2022―Apr―29 |
Demographic, clinical, investigational characteristics of COVID-19 related Guillain-Barré syndrome with differences from typical and another virus-related Guillain-Barré syndrome |
Jitendra Singh, Nilesh Kumar, Anju Dinkar |
| 37 |
[GO] |
2022―Apr―26 |
‘Convalescent Plasma’- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review |
Sumel Ashique, Tahamina Khatun, Garima Sahu, Aakash Upadhyay, Archana Adhana, Nitish Kumar, et al. (+2) Shubneesh Kumar, Navjot Sandhu |
| 38 |
[GO] |
2022―Apr―25 |
Infection and Severity of COVID-19 infection among health care workers: A report from Egypt |
Ehab F Moustafa, Sahar M Hassany, Asmaa Mohamed Ahmed Soliman, Mohammed Ezz-Eldin, Nariman Zaghloul, Sherief Abd-Elsalam |
| 39 |
[GO] |
2022―Apr―25 |
The emergence of Omicron SARS-CoV-2 variant (B.1.1.529) - the latest episode in the COVID-19 pandemic with a global riposte |
Suman Kumar Ray, Sukhes Mukherjee |
| 40 |
[GO] |
2022―Apr―22 |
Epigenetic-related effects of COVID-19 on the human cells |
Arezoo Faramarzi, Reza Safaralizadeh, Narges Dastmalchi, Shahram Teimourian |
| 41 |
[GO] |
2022―Apr―20 |
A clinically validated, broadly active, oral viral superinfection therapy could mitigate symptoms in early-stage COVID-19 patients |
Tibor Bakacs, Volker Sandig, Shimon Slavin, Serhat Gumrukcu, W David Hardy, Wolfgang Renz, Imre Kovesdi |
| 42 |
[GO] |
2022―Apr―20 |
Prevalence, presentation and outcome of secondary bloodstream infections among the COVID-19 patients |
Subhashree Samantaray, Priyabrat Karan, Anuradha Sharma, Vijayalakshmi Nag, Naveen Dutt, Mahendra Kumar Garg, et al. (+2) Pradeep Kumar Bhatia, Sanjeev Misra |
| 43 |
[GO] |
2022―Apr―20 |
COVID-19 vaccination, Peltzman Effect and possible increase in high-risk behaviors: a growing concern on risk compensation and reduced compliance to Public Health protective Measures after vaccines rollout |
Shahab Falahi, Jasem Mohamadi, Hojjat Sayyadi, Iraj Pakzad, Ayoub Rashidi, Razi Naserifar, et al. (+2) Jahangir Abdi, Azra Kenarkoohi |
| 44 |
[GO] |
2022―Apr―07 |
COVID-19 and Co-infections: A Serious Health Threat Requires Combination Diagnosis and Therapy |
Shahid Nawaz, Maira Saleem |
| 45 |
[GO] |
2022―Apr―07 |
SARS-CoV-2-Induced Neurological Disorders in Symptomatic Covid-19 and Long Covid Patients: Key Role of Brain Renin-Angiotensin System |
Ziad Fajloun, Hervé Kovacic, Cédric Annweiler, Yingliang Wu, Zhijian Cao, Jean-Marc Sabatier |
| 46 |
[GO] |
2022―Apr―03 |
A new wave of COVID-19 in 2021 with unique genetic characters -present global scenario and beholding onwards |
Sukhes Mukherjee, Suman Kumar Ray |
| 47 |
[GO] |
2022―Mar―25 |
Technology in the Era of COVID-19: A Systematic Review of Current Evidence |
Esmaeil Mehraeen, Mohammad Mehrtak, SeyedAhmad SeyedAlinaghi, Zahra Nazeri, Amir Masoud Afsahi, Farzane Behnezhad, et al. (+6) Farzin Vahedi, Alireza Barzegary, Amirali Karimi, Nahid Mehrabi, Omid Dadras, Shayesteh Jahanfar |
| 48 |
[GO] |
2022―Mar―23 |
Therapeutic strategies for COVID-19 patients: An update |
Muhammad Ibrahim Getso, So�h Etemadi, Vahid Raissi, Moein Mohseni, Maedeh Sadat Mohseni, Farid Raeisi, Omid Raiesi |
| 49 |
[GO] |
2022―Mar―22 |
An update review on complicated mechanisms of COVID-19 pathogenesis and therapy: direct viral damage, renin-angiotensin system dysregulation, immune system derangements, and endothelial dysfunction |
Shahab Falahi, Maryam Maleki, Azra Kenarkoohi |
| 50 |
[GO] |
2022―Mar―22 |
An Insight of Clinical Evidences of Ayurveda Interventions in the Management of COVID-19 Patients |
Naina Mohamed Pakkir Maideen, Rajkapoor Balasubramaniam, Gobinath Manavalan, Kumar Balasubramanian, Vasanth Kumar S |
| 51 |
[GO] |
2022―Mar―18 |
DO METHYLENE BLUE SATISFIES AN OPTION - IN COVID-19 ARDS |
Sri Hari TY, Sree Sudha TY, Krishna Sasanka KSBS, Pugazhenthan Thangaraju |
| 52 |
[GO] |
2022―Mar―18 |
Original antigenic sin in COVID-19: Hoskins effect and vaccine |
Mudassir Khan, Sobia Manzoor, Najeeb Ullah, Dilawar Khan |
| 53 |
[GO] |
2022―Feb―25 |
The Persistence Time of SARS-CoV-2 RNA in hospitalized COVID-19 Patients: A prospective Study |
Jila Yavarian, Mohammad Javaherian, Somayeh Shatizadeh Malekshahi, Zahra Ahmadinejad, Fatemeh Ghiasvand, Elaheh Ahmadi, et al. (+6) Ladan Abbasian, Malihe Hasannezhad Malihe Hasannezhad, Narges Dabaghipour, Nazanin-Zahra Shafiei-Jandaghi, Talat Mokhtari-azad, Mahboubeh Hajiabdolbaghi |
| 54 |
[GO] |
2022―Feb―22 |
Impact of tocilizumab on inflammatory markers and oxygen status in severe covid-19 patients: A single centre retrospective study. |
Abhishek Sharma, Deepak Nathiya, Supriya Suman, Hemant Bareth, Mahaveer Singh, Eshan Sharma |
| 55 |
[GO] |
2022―Feb―21 |
A Review on the New Indication of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in the Treatment of Coronavirus Disease 2019 |
Hedyieh Karbasforooshan, Sofia Salari, Hesamoddin Hosseinjani |
| 56 |
[GO] |
2022―Feb―16 |
Covid-19 Study, Pathology and Therapeutics |
Da-Yong Lu |
| 57 |
[GO] |
2022―Feb―09 |
Third waves of the COVID-19 pandemic: Prominence of initial public health Interference |
Sukhes Mukherjee, Suman Kumar Ray |
| 58 |
[GO] |
2022―Jan―28 |
Gallium Components-Based Drug Delivery: A Potential Treatment for COVID-19 |
Sara Torabi, Farbod Bahreini, Nima Rezaei |
| 59 |
[GO] |
2022―Jan―28 |
A case of multiple sclerosis with protracted course of COVID-19 |
Mehrdad Hasibi, Marjan Asadollahi, Ali Asadollahi-Amin |
| 60 |
[GO] |
2022―Jan―28 |
Diagnostic Stewardship in Times of Covid-19 Pandemic |
Lipika Singhal, Ivneet Kour, Varsha Gupta |
| 61 |
[GO] |
2022―Jan―24 |
An Overview of Antiviral Properties of Bacteriophages with Emphasis on the Treatment of COVID-19 Infection |
Mahsa Jalili, Nastaran Ansari, Behzad Pourhossein, Maryam Fazeli, Farid Azizi Jalilian |
| 62 |
[GO] |
2022―Jan―20 |
Molecular docking of phytochemical compounds of Momordica charantia as potential inhibitor against SARS-CoV-2 |
Yayu Mulsiani Evary, Ayu Masyita, Arie Ariezandi Kurnianto, Rangga Meidianto Asri, Yusnita Rifai |
| 63 |
[GO] |
2022―Jan―19 |
Ivermectin in COVID-19 Management: What is the current evidence? |
Madhavi Eerike, Gerard Marshall Raj, Rekha Priyadarshini, Gandham Ravi, Debasis Bisoi, Venu Gopala Rao Konda |
| 64 |
[GO] |
2022―Jan―18 |
Procalcitonin as a prognostic factor in patients with COVID-19 in southwestern Iran |
Milad Shahini Shams Abadi, Elham Taheri, Ahmad Raesi, Mohammad-Hassan Arjmand, Soleiman Kheirii, Najmeh Shahinfard, Zahra Habibi |
| 65 |
[GO] |
2022―Jan―18 |
Therapeutic Status of Famotidine in COVID-19 Patients: A Review |
Moein Mohseni, Vahid Raissi, Yasamin Sharifan, Kimia Barikro, Sasan Amiri, Maedeh Sadat Mohseni, et al. (+4) Farid Raeisi, Kimia Masoumi, Sina Khodakarami, Omid Raiesi |
| 66 |
[GO] |
2022―Jan―18 |
Challenges in Engendering Herd Immunity to SARS-CoV-2 infection: Possibly Impossible but Plausibility with Hope |
Sukhes Mukherjee, Suman Kumar Ray |
| 67 |
[GO] |
2022―Jan―06 |
COVID-19 Infection in Pregnancy: A Review |
Sabrina Jahan Mily, Kazi Mahmuda Akter, Nowshin Jabin, Saikat Mitra, Talha Bin Emran, Monisha Nandi, et al. (+8) Sumit Kumar Baral, Md. Zia Uddin, Jewel Mallick, Arkajyoti Paul, Syed Uzair Ali Shah, Abdur Rauf, Ishaq N. Khan, Mohammad S. Mubarak |
| 68 |
[GO] |
2022―Jan―06 |
The chance of COVID-19 infection after vaccination |
Ghazaleh Khalili-Tanha, Majid Khazaei, Saman Soleimanpour, Gordon A Ferns, Amir Avan |
| 69 |
[GO] |
2021―Dec―02 |
Case Report: Severe SARS-CoV-2 Infection with Remdesivir in a Patient with ESRD |
Raj H. Patel, Pablo M. Pella, Naeem Haider, Renato Blanco |
| 70 |
[GO] |
2021―Sep―30 |
COVID-19 in pediatrics: The current knowledge and practice |
Esmaeil Mehraeen, Shahram Oliaei, SeyedAhmad SeyedAlinaghi, Amirali Karimi, Pegah Mirzapour, Amir Masoud Afsahi, et al. (+9) Alireza Barzegary, Farzin Vahedi, Mahdi Soleymanzadeh, Farzane Behnezhad, Mohammad Javaherian, Ghazal Zargari, Seyed Peyman Mirghaderi, Tayebeh Noori, Jean-Marc Sabatier |
| 71 |
[GO] |
2021―Sep―23 |
Vaccines for COVID-19: A Review of Feasibility and Effectiveness |
Esmaeil Mehraeen, Omid Dadras, Amir Masoud Afsahi, Amirali Karimi, Mehrzad MohsseniPour, Pegah Mirzapour, et al. (+11) Alireza Barzegary, Farzane Behnezhad, Pedram Habibi, Mohammad Amin Salehi, Farzin Vahedi, Mohammad Heydari, Shaghayegh Kianzad, Banafsheh Moradmand-Badie, Mohammad Javaherian, SeyedAhmad SeyedAlinaghi, Jean-Marc Sabatier |
| 72 |
[GO] |
2021―Sep―16 |
Liver injury in COVID-19: A Direct hit or Collateral damage? |
Balasubramaniyan Vairappan, Gavin Wright, Douglas Corrigal |
| 73 |
[GO] |
2021―Sep―13 |
Counter-Regulatory Renin-Angiotensin System: An Important Line of Research to Understand and Limit the Severity of COVID-19 |
Cédric Annweiler, Zhijian Cao, Nicolas Papon, Hervé Kovacic, Jean-Marc Sabatier |
| 74 |
[GO] |
2021―Sep―07 |
Persistent Hiccups as an Atypical Initial Presentation of COVID-19: A Case Report |
Omid Dadras, Alimohamad Asghari, Atefe Nosratzahi |
| 75 |
[GO] |
2021―Sep―06 |
SARS-CoV-2 transmission among health care workers in Iran: an urgent need for early identification and management |
Mohammad Reza Abdolsalehi, Shima Mahmoudi, Reza Shervin Badv, Babak Pourakbari, Keyvan Mirnia, Yasmine Mahmoudieh, Setareh Mamishi |
| 76 |
[GO] |
2021―Aug―30 |
DAMPening Severe COVID-19 with Dexamethasone |
Cédric Annweiler, Nicolas Papon, Jean-Marc Sabatier, Jean Barré |
| 77 |
[GO] |
2021―Aug―11 |
Can Antimalarial Phytochemicals be a Possible Cure for COVID-19? Molecular Docking Studies of Some Phytochemicals to SARS-CoV-2 3C-like Protease |
Anamul Hasan, Khoshnur Jannat, Tohmina Afroze Bondhon, Rownak Jahan, Md Shahadat Hossan, Maria de Lourdes Pereira, et al. (+3) Veeranoot Nissapatorn, Christophe Wiart, Mohammed Rahmatullah |
| 78 |
[GO] |
2021―Jul―27 |
Current Treatments and Therapeutic Options for COVID-19 Patients: A Systematic Review |
Esmaeil Mehraeen, Zeinab Najafi, Bagher Hayati, Mohammad Javaherian, Sajad Rahimi, Omid Dadras, et al. (+3) SeyedAhmad SeyedAlinaghi, Maryam Ghadimi, Jean-Marc Sabatier |
| 79 |
[GO] |
2021―Jul―25 |
Genetics and Vaccine development for SARS-CoV2 in the era of Personalized Medicine |
Eirini Konstantina Tafanidou, Despoina Gkentzi |
| 80 |
[GO] |
2021―Jul―19 |
Shared Food, Meals and Drinks: 10 Arguments Suggesting an Oral Transmission Route of SARS-CoV-2 |
Jean-Michel Wendling, Aure Saulnier, Jean-Marc Sabatier |
| 81 |
[GO] |
2021―Jun―16 |
Hypothesis: Designation of Liposomal Scavenger System for Fighting against 2019-nCoV |
Nooshin Bagherani, Bruce R. Smoller |
| 82 |
[GO] |
2021―May―28 |
A short review on key role of plants and their extracts in boosting up immune response to combat COVID-19 |
Mudassir Khan, Muhammad Abu Bakar Saddique, Huzaifa Tahir, Muhammad Dawood Amjad, Abdullah Ahmad, Usama Masood, Dilawar Khan |
| 83 |
[GO] |
2021―Mar―23 |
Investigation of structural, treatment and clinical characteristics of COVID-19 along with the challenges caused by its prevalence |
Maham Doagooyan, Seyedeh Hoda Alavizadeh, Javad Akhtari, Amirhossein Sahebkar, Saeed Ghanbari Hasan Kiade, Pariya Haghgoo Kochesfahani, Fatemeh Gheybi |
| 84 |
[GO] |
2021―Mar―03 |
COVID-19 and Infectious Disease Speciality - A necessity of Time in India. |
Gopal K Bohra, Deepak Kumar, Mahendra K Garg |
| 85 |
[GO] |
2021―Mar―03 |
The recovery of an elderly woman with asthma and diabetes from COVID-19 infection: a case report |
Abas Ghaysouri, Maryam Safari, Elham Mohammadyari, Firooz Balavandi, Ali Nazari, Jalil Feizi, et al. (+4) Mohamad Karimian, Elham Bastani, Ebrahim Salimi, Hamed Tavan |
| 86 |
[GO] |
2021―Mar―01 |
A mini review on the pathogenesis, diagnosis and treatment options for COVID-19 |
Farzad Rahmani, Aghigh Ziaeemehr, Sajede Alijannejad, Gordon A Ferns, Majid Khazaei, Soodabeh Shahidsales, Amir Avan |
| 87 |
[GO] |
2021―Mar―01 |
COVID-19: Potential Repurposing Drugs |
Wattana Leowattana |
| 88 |
[GO] |
2021―Feb―19 |
COVID-19 and Neurology - An Emerging Association |
Amit Gupta, Prakrati Yadav, Deepak Kumar |
| 89 |
[GO] |
2021―Feb―19 |
Natural Derived Nasal Spray; a Proposed Approach for COVID-19 Disease Control |
Zahra Hoseini-Tavassol, Hanieh-Sadat Ejtahed, Ahmad-Reza Soroush, Zahra Sajjadpour, Shirin Hasani-Ranjbar, Bagher Larijani |
| 90 |
[GO] |
2021―Feb―19 |
Hepatic involvement as Hyperbilirubinemia in Patients with COVID-19: Case Series from Iran |
Ahmad Hormati, Mohammad Reza Ghadir, Mohammad Saeidi, Reza Aminnejad, Mahboubeh Afifian, Sajjad Ahmadpour |
| 91 |
[GO] |
2021―Feb―04 |
COVID-19 and Alcohol Misuse: A Case Report |
Ali Asadollahi-Amin, Ali Nowroozi, Mehrdad Hasibi, Behzad Asanjarani, SeyedAhmad SeyedAlinaghi |
| 92 |
[GO] |
2021―Feb―04 |
Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a patient with Hodgkin's lymphoma history from north of Iran |
David Darvishnia, Mahdieh Sadeghi, Ali Sharifpour, Zakaria Zakariaei, Elham Sadat Banimostafavi, Mahdi Fakhar, Rabeeh Tabaripour |
| 93 |
[GO] |
2021―Jan―19 |
The Role of Justicia Adhatoda as prophylaxis for COVID-19 - Analysis based on docking study |
Pugazhenthan Thangaraju, Sree Sudha TY, Praveen Kumar Pasala, Sri Hari TY, Sajitha Venkatesan, Eswaran Thangaraju |
| 94 |
[GO] |
2021―Jan―05 |
SARS-CoV-2: An insight into detection tools |
Shaghayegh Khanmohammadi, Mohammadreza Tabary, Farnaz Araghi, Seyed Mohammad Tavangar |
| 95 |
[GO] |
2021―Jan―05 |
Modifications of Medical Care of Chronic Liver Diseases during COVID19 Pandemic: Necessity or Novelty? |
Hanan Hamed Soliman, Mohamed H. Emara, Mahmoud Elkadeem, Sherief Abd-Elsalam |
| 96 |
[GO] |
2021―Jan―04 |
An Updated Review on COVID-19 |
Mahmoud Ahmed Ebada, Ahmed Wadaa Allah, Eshak Bahbah, Ahmed Negida |
| 97 |
[GO] |
2020―Dec―21 |
Pharmacological strategies for COVID-19 - A review of the most promising repurposed antiviral drugs. |
Deepti Chopra, Jaspreet K Boparai, Bharti Bhandari, Anurag Srivastava, Rakesh Gupta |
| 98 |
[GO] |
2020―Dec―21 |
Possible therapeutic interventions in COVID-19 induced ARDS by cotinine as an ACE-2 promoter and AT-1R blocker |
Tarun Sharma, Sidharth Mehan |
| 99 |
[GO] |
2020―Dec―10 |
Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report |
SeyedAhmad SeyedAlinaghi, Maryam Ghadimi, Mehrnaz Asadi Gharabaghi, Fereshteh Ghiasvand |
| 100 |
[GO] |
2020―Dec―10 |
Coronavirus Disease 2019: Virology and Drug Targets |
Praveen Thaggikuppe Krishnamurthy |
| 101 |
[GO] |
2020―Dec―08 |
Evaluation of the Binding Affinity of Anti-Viral Drugs against Main Protease of SARS-CoV-2 through a Molecular Docking Study |
Milon Mondal, Chandan Sarkar, Sarmin Jamaddar, Abul Bashar Ripon Khalipha, Muhammad Torequl Islam, Azmi Mahafzah, Mohammad S. Mubarak |
| 102 |
[GO] |
2020―Nov―27 |
COVID-19 Treatment Success After Repeat Courses of Azithromycin: a report of three cases |
Fereshteh Ghiasvand, Maryam Ghadimi, Sara Sadr, Fatemeh Jafari, Navid Manafi, Zahra Ah-madinejad, et al. (+2) Samaneh Tirgar, Seyed Ahmad Seyed Alinaghi |
| 103 |
[GO] |
2020―Nov―17 |
Pharmacological inhibition of MMP3 as a potential therapeutic option for COVID-19 associated acute respiratory distress syndrome |
Rana Kadry, Andrea Sikora Newsome, Payaningal R. Somanath |
| 104 |
[GO] |
2020―Nov―17 |
A Patient with COVID-19 Pneumonia Presenting with Plural Effusion: A Case Report. |
Fereshteh Ghiasvand, SeyedAhmad SeyedAlinaghi, Samaneh Tirgar, Mohamad Reza Salehi, Banafsheh Moradmand-Badie |
| 105 |
[GO] |
2020―Nov―17 |
Transmission Modes of COVID-19: A Systematic Review |
Esmaeil Mehraeen, Mohammad Amin Salehi, Farzane Behnezhad, Hamed Rezakhani Moghaddam, SeyedAhmad SeyedAlinaghi |
| 106 |
[GO] |
2020―Nov―13 |
Postoperative COVID-19 pneumonia in an asymptomatic patient: a case report |
Ali Asadollahi-Amin, Elnaz Shahmohamadi, Mehrdad Hasibi, Maryam Moosivand, Maryam Taghizadeh, Seyed Ahmad Seyed Alinaghi |
| 107 |
[GO] |
2020―Nov―10 |
An overview on COVID-19 pandemic: from discovery to treatment |
Kalpana Panati, Venkatramana Reddy Arva Tatireddygari, Venkata Ramireddy Narala |
| 108 |
[GO] |
2020―Oct―30 |
Efficacy of Lopinavir/Ritonavir Compared With Standard Care for Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review |
Timotius Ivan Hariyanto, Elizabeth Kristine, Catherine Jillian Hardi, Andree Kurniawan |
| 109 |
[GO] |
2020―Oct―20 |
A Viewpoint On Potential Biomarkers For Infectious COVID-19 severity: An Updated Literature Survey |
Suraj N. Mali, Fatemeh Mohajer, Ghodsi Mohammadi Ziarani, Amit P. Pratap |
| 110 |
[GO] |
2020―Oct―18 |
BCG vaccine, a ray of hope in treating Severe Acute Respiratory Syndrome (SARS) |
Amit Bandyopadhyay Banerjee, Thakur Gurjeet Singh, Abhimanyu Prashar |
| 111 |
[GO] |
2020―Oct―14 |
COVID-19 And Type 2 Diabetes Mellitus: Hydroxychloroquine May Be The Holy Grail |
Rimesh Pal, Manoj K. Bhasin, Sanjay K. Bhadada |
| 112 |
[GO] |
2020―Oct―07 |
Covid-19, SARS -CoV-2, Origin, transmission and treatment aspects, a brief review |
Shahid Nawaz |
| 113 |
[GO] |
2020―Sep―22 |
Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction |
Nahid Akhtar, Amit Joshi, Bhupender Singh, Vikas Kaushik |
| 114 |
[GO] |
2020―Sep―05 |
Impact of COVID-19 on Indian Pharmaceutical Industry and WayForward |
Nikita Vijay Jadhav, Nisha Singh, Monika Targhotra, Meenakshi K. Chauhan |
| 115 |
[GO] |
2020―Aug―05 |
Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein |
Bipin Singh |
| 116 |
[GO] |
2020―Jul―30 |
Ocular COVID-19: Eyes as a reservoir to conceal and spread SARS-CoV-2 |
Abdul Mannan Baig, Saara Ahmad, Areeba Khaleeq, Hamna Rafique, Shafiqa Rajput, Mehaer Angez, et al. (+3) Ayesha Hameed, Talha Nawaz, Preet Katyara |
| 117 |
[GO] |
2020―Jul―28 |
In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases |
Trinath Chowdhury, Gourisankar Roymahapatra, Santi M. Mandal |
| 118 |
[GO] |
2020―Jul―27 |
Chloroquine as chemoprophylaxis for COVID-19: Will this work? |
Sherief Abd-Elsalam, Mahmoud Elkadeem, Khadija Ahmed Glal |
| 119 |
[GO] |
2020―Jul―21 |
Newly Emergent 2019-nCoV and New Uses of an Old Medicine, Doxycycline; A Hypothesis. |
Tommy Richard Sun-Wing TONG |
| 120 |
[GO] |
2020―Jun―22 |
Targeting infectious Coronavirus Disease 2019 (COVID-19) with Artificial Intelligence (AI) applications: Evidence based opinion |
Suraj N. Mali, Amit P. Pratap |
| 121 |
[GO] |
2020―Jun―09 |
Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report |
Zahra Ahmadinejad, Faeze Salahshour, Omid Dadras, Hesan Rezaei, SyyedAhmad Alinaghi |
| 122 |
[GO] |
2020―May―21 |
Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital |
Fereshteh Ghiasvand, SeyedAhmad SeyedAlinaghi |
| 123 |
[GO] |
2020―May―20 |
SARS-CoV-2: The Path of Prevention and Control |
Amal A. Mohamed, Nouran Mohamed, Seham Mohamoud, Fawkia E. Zahran, Rania Abdelmonem Khattab, Dalia Ali El-Damasy, et al. (+2) Eman Alsayed, Sherief Abd-Elsalam |
| 124 |
[GO] |
2020―May―18 |
Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients |
Cédric Annweiler, Zhijian Cao, Yingliang Wu, Emmanuelle Faucon, Stéphanie Mouhat, Hervé Kovacic, Jean-Marc Sabatier |
| 125 |
[GO] |
2020―May―11 |
A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19) |
Suraj N. Mali, Bapu R. Thorat, Atul R. Chopade |
| 126 |
[GO] |
2020―May―06 |
SARS-CoV-2 & Covid-19: Key-Roles of the ‘Renin-Angiotensin’ System / Vitamin D Impacting Drug and Vaccine Developments |
Zhijian Cao, Yingliang Wu, Emmanuelle Faucon, Jean-Marc Sabatier |
| 127 |
[GO] |
2020―Apr―29 |
A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case |
Fereshteh Ghiasvand, Sepideh Zahak Miandoab, Hamid Harandi, Fereshteh Shahmari Golestan, Seyed Ahmad Seyed Alinaghi |
